CPIP has published a new policy brief celebrating the fortieth anniversary of the Diamond v. Chakrabarty decision, where the Supreme Court in 1980 held that a genetically modified bacteria was patentable subject matter. The brief, entitled Forty Years Since Diamond v. Read more
Tag: biotech
Mark Schultz: Weaker Patent Protection Leads to Less Venture Capital Investment
The following post comes from David Ward, a 2L at Scalia Law and a Research Assistant at CPIP.
By David Ward
Venture capitalists pouring money into a small startup has become a sort of new American Dream for many innovators. The success stories of big American companies starting with nothing more than an idea have pervaded their way into pop culture, inspiring TV shows, movies, and the like. Read more
A Critique of a Recent Article Which Found That Sequence Patents Cover the Entire Human Genome
By Professor Christopher Holman
[The following is a blog posting by Christopher Holman, a patent law scholar at UMKC School of Law, that he originally posted on April 5, 2013 at his blog, Holman’s Biotech IP Blog, where Professor Holman regularly blogs on important issues in biotech and IP law. Read more